Susan Brooks

Susan Brooks


Brooks Supports Cutting the National Debt and Holding the Administration Accountable for Spending


WASHINGTON, D.C.— Today, the House passed H.R. 3442, the Debt Management and Fiscal Responsibility Act, which requires the Administration to appear before Congress prior to each potential debt limit increase and provide testimony and detailed reports on (i) the national debt and its key drivers; (ii) explicit short, medium, and long-term debt reduction proposals; and (iii) progress on debt reduction. Following passage, Congresswoman Susan W. Brooks (R-IN) released the following statement:

“Our national debt is out of control, and today I’m proud to act to increase transparency and accountability to make sure that Congress and the American people are better informed about the debt, its risks and economic impact, as well as steps that we can take to get our financial house in order. We are continually faced with 11th hour ultimatums related to our debt limit. It is unacceptable, and under this proposal, the Administration will be held accountable for providing timely solutions to our growing debt and reporting to the American people our progress in reducing our national debt.”

H.R. 3442 requires the Treasury Secretary to appear before the House Ways and Means Committee and the Senate Finance Committee not more than 60 days and not less than 21 days prior to any date on which the Treasury Secretary anticipates that the nation will reach the debt limit. Before the Committees, the Treasury Secretary shall present the following which will also be made available to the public:

  • Debt Report to Congress on (i) the state of the national debt, the historical levels of debt, (ii) current amount and composition of the debt, and future debt projections; and (iii) the Administration’s plans to meet debt obligations in the event that Congress agrees to raise the debt limit.
  • Statement of Intent on how the Administration proposes to reduce the debt in the short, medium, and long-term, and the economic impact of an increased debt limit.
  • Progress Report on the implementation of the Statement of Intent proposals by the Administration to reduce U.S. debt levels. 
Read More

House Passes Safe Drinking Water Act to Protect People from Contaminated Water


WASHINGTON, D.C.— Yesterday, the House passed H.R. 4470, the Safe Drinking Water Act Improved Compliance Awareness Act, a bill that ensures the public will learn of excessive lead levels in drinking water by setting forth how and when states, EPA and drinking water utilities must communicate their findings. Following passage, Congresswoman Susan W. Brooks (R-IN) released the following statement:

“Clean, safe water is fundamental to our communities. In Flint, Michigan, the EPA did not let people know that the water they were drinking contained dangerous levels of lead. This legislation requires the EPA as well as water utilities and states to let people know when elevated levels of lead are detected in drinking water. Moreover, the EPA must create a plan to ensure that information about the quality of drinking water flows quickly and effectively between local and state governments, water utilities and consumers.”

“Recently, a community in my district, Greentown, Indiana, discovered levels of lead in the water that caused concern at a local school after conducting independent testing. As a result of miscommunication between the school system and the local utility, the school system was not independently notified when some local residents received letters last October indicating that high levels of lead had been detected in local drinking water. Simple, no-cost solutions that encourage information sharing between consumers, local governments and regulators can help prevent situations like the one in Greentown, and better protect us from lead in our drinking water. ” 

H.R. 4470 would:

  • Require public notification when enforceable requirements for lead in drinking water are exceeded.
    • Public water systems must notify their consumers if the lead action level is exceeded in their drinking water system.
    • When a lead action level is exceeded for the 90th percentile of a public water system’s customers, (causing significant potential for adverse health consequences) EPA must quickly notify the public if the state or local drinking water system fails to do so.
  • Require EPA to create a strategic plan for handling and improving information flow between drinking water utilities, the states, EPA, and affected drinking water consumers when there is an enforceable lead exceedance in drinking water.
  • Ensure all levels of government communicate with each other.
  • Require consumer notification when water being transported in a lead pipe is sufficiently corrosive that it could leach lead into public drinking water.
Read More

US, EU & WHO Launch Efforts to Accelerate Zika R&D


One week after the World Health Organization (WHO) declared a public health emergency in response to Zika-linked clusters of microcephaly, it and authorities in the US and EU are mobilizing to accelerate the development of treatments and diagnostics for the disease.

Obama Calls for $1.8 Billion in Funding

On Monday, the White House announced it will ask Congress for more than $1.8 billion to establish an emergency fund to combat the Zika virus in the US and abroad.

Nearly $1.5 billion would be allocated to the Department of Health and Human Services (HHS), while the remaining funds would be allocated to the U.S. Agency for International Development (USAID) and the State Department.

The lion's share of the funding to HHS would be given to the Centers for Disease Control and Prevention (CDC) to bolster defensive efforts against mosquitoes, conduct research into the link between Zika and microcephaly, improve surveillance and develop diagnostics for the disease.

As part of the package, the president is requesting $250 million to go to Puerto Rico's Medicaid Federal Medical Assistance Program (FMAP) to increase health services for pregnant women and children with microcephaly in the territory. On Friday, Puerto Rico declared Zika a public health emergency, and the CDC reports the territory is experiencing active transmission of the virus.

The fund would also include $200 million to support the development and use of vaccines and diagnostics and would make resources available to FDA to "support Zika virus medical product development including next generation diagnostic devices."

A Priority Review Voucher for Zika?

On 1 February 2016, Rep. G.K. Butterfield (D-NC) and Rep. Susan Brooks (R-IN) submitted a bill to add the Zika virus to the list of tropical diseases eligible for a priority review voucher from FDA to further incentivize development of products to treat the disease.

"Work is already underway to create a vaccine, but without a Priority Review Voucher in place, a vaccine may not be available for years," Brooks said.

If added, any company that gets product approved to treat Zika would be granted a priority review voucher, which guarantees a six-month priority review for a future product. These vouchers have proven to be highly valuable. In August 2015, United Therapeutics sold one to AbbVie for a record-setting $350 million.

Last Wednesday, Senators Lamar Alexander (R-TN) and Richard Burr (R-NC) sent a letter to HHS pressing the agency on whether it planned to add Zika to the list of tropical diseases eligible for a priority review voucher. Under the Food and Drug Administration Amendments Act both Congress and FDA have the ability to add diseases to the program.

EMA Task Force

On Monday, EMA announced the launch of a new task force intended to advise sponsors on scientific and regulatory issues for products in development to treat or prevent Zika.

"There are currently no vaccines or medicines to protect from or treat Zika virus infection that are approved or undergoing clinical studies," EMA notes in a press release.

The agency says the task force will include vaccine and infectious disease experts who can provide guidance to sponsors on clinical trial design, manufacturing issues, and postmarket surveillance.

EMA is also encouraging sponsors to contact the agency if they are working on any "promising projects" related to Zika. Additionally, the agency says it will "proactively reach out to companies already planning to work on investigational vaccines."

These efforts, the agency says, have the potential to "significantly speed up the development of medicines."

EMA says it can also leverage its experts to assist in product reviews under the Article 58 procedure, which allows the agency to review products "intended exclusively for markets outside the European Union."

European Commission Funding

Just days before WHO made its declaration, Carlos Moedas, EU commissioner for research, science and innovation, announced the commission would devote €10 million to finance the development of vaccines to treat Zika.

"As Commissioner responsible for Research, Science and Innovation, I believe I must use all the means at my disposal within the Horizon 2020 programme to contribute to the international efforts underway to tackle the spreading Zika virus," Moedas said in a blog post.

The funding will come out of the €50 million earmarked for vaccine development in 2016-17 under the Horizon 2020, an €80 billion program to promote research and innovation across a number of sectors in the EU.

WHO Emergency Assessment: Diagnostics and Vaccines

On Friday, WHO issued a call urging companies to submit products, especially diagnostics, to the agency's emergency use assessment and listing (EUAL) procedure.

"Diagnostics are a top urgency in order to ascertain the presence of the Zika virus as opposed to other similar diseases … very few tests are available," the agency said in a press release Monday.

Under the procedure, WHO reviews products to determine "acceptable levels of quality and performance and allows UN agencies, NGOs and countries to procure the product with confidence."

The EUAL procedure was first established to expedite the review of vaccines, drugs and diagnostics during WHO's response to the 2014 Ebola outbreak in West Africa.

According to WHO, at least 12 groups are in the early stages of development for Zika virus vaccines, and others are investigating the use of prophylactic drugs to prevent the disease.

The agency also says efforts to control mosquito populations including fogging and the release of genetically modified mosquitoes "may be worth considering."

Read More

Brooks calls on FDA to act on Zika virus


U.S. Rep. Susan Brooks (R-IN) led 70 members of Congress on Friday in a letter to U.S. Food and Drug Administration (FDA) Acting Commissioner Dr. Stephen Ostroff calling for Zika virus to be added to the FDA Tropical Disease Priority Review Voucher (PRV) Program.

The letter follows a Monday meeting by the World Health Organization (WHO) to address the growing threat that Zika virus poses in the Americas.

“Zika virus is spreading rapidly in South and Central America,” Brooks said. “We must act to ensure that our citizens are protected, and that we are doing everything we can to prevent an outbreak of Zika virus in the United States. A natural first step would be for the FDA to exercise its authority and fast-track the development of vaccines or treatments for Zika virus helping save lives and prevent infections.”

Developing new vaccines and treatments takes several years and cost hundreds of millions of dollars, but placing the Zika virus in the FDA Tropical Disease PRV Program would incentivize research and development of vaccines and therapies to fight the virus by allowing a PRV to be requested by drug manufacturers, who would also receive expedited FDA consideration.

“While the development of vaccines is already underway, it could take years before a vaccine is widely available,” Brooks said. “In a situation like this — when the WHO has estimated that up to four million people in the Americas will be infected by the end of the year — we don’t have the luxury of time. I will continue to pursue actions and legislative fixes that will help protect our country from dangerous diseases and help arm our researchers with the resources they need to combat the challenges of any potential epidemic or outbreak before it occurs.”

Brooks cosponsored legislation, H.R. 4400, on Feb. 1 that would add Zika virus to the FDA Tropical Disease PRV Program.

Zika virus symptoms are considered relatively mild and include fever, rash, joint pain and red eyes. Symptoms themselves are only developed by one-in-five infected with the virus. Zika virus, however, has also been linked to a surge in infants born with unusually small heads and underdeveloped or damaged brains.

There is no widely available test for Zika virus infection, nor is there a vaccine.

  Read More

Brooks Reacts to Administration’s Request for Emergency Funding to Combat Zika Virus


WASHINGTON, D.C.— Following Monday’s announcement by the Administration that an additional $1.8 billion in funding would be needed for an emergency fund to combat the Zika virus in the U.S. and abroad, Congresswoman Susan W. Brooks (R-IN) released the following statement:

“The announcement by the White House that $1.8 billion in emergency funds is needed to combat the Zika virus outbreak is further evidence of how unprepared we are as a country to meet the challenges that biological threats present to our nation’s health and security. In the midst of the 2014 Ebola outbreak, the Administration took the same steps and called for emergency funds, and now, two years later we find ourselves in the same situation with no significant progress to protect our citizens from these threats. We need to have an infrastructure in place prepared to take on a crisis before it breaks that includes taking preventative steps to develop treatments and vaccines so we are ready before an outbreak takes hold. I urge the Administration to consider all options, including adding Zika virus to the Food and Drug Administration (FDA) Tropical Disease Priority Review Voucher Program, a no-cost action that will incentivize the development, testing and distribution of a vaccine or treatment for Zika virus today.”

Read More

Brooks receives leadership award


ANDERSON – U.S. Rep. Susan Brooks received a Congressional Leadership Award last week for her legislative efforts at the federal level to combat substance abuse.

Brooks, R-5th District, received the leadership award from the Community Anti-Drug Coalitions of America during the group’s 26th annual leadership forum.

The Congressional Leadership Award recognizes members of Congress who have championed legislation and strategies to protect and enhance the federal role in substance abuse prevention, education, treatment and research.

“I have seen the devastating effects of substance abuse firsthand in our prisons, our courts, and in our families,” Brooks said in a press release. “Communities in Indiana and across this country are seeing an ever-growing number of people struggling with addiction and substance abuse, and the members of CADCA are critical partners on the front lines combating the heroin and opioid abuse epidemic that we’re facing today.”

“Substance abuse and addiction are diseases, and we have to work together, as CADCA has done, to treat and prevent them," Brooks said in the release.

Brooks has introduced legislation that targets several areas of need critical to reducing the number of painkiller and heroin overdose deaths each year.

The legislation will provide new guidance and best practices to members of the medical community, reauthorize prescription drug monitoring programs critical to local law enforcement efforts, increase access to life-saving Naloxone and raise public, provider, and patient awareness of the risks of opioid drugs.

It is the companion bill to legislation introduced by Sens. Joe Donnelly, D-Ind., and Kelly Ayotte, R-N.H.

Brooks also serves on the Congressional Addiction, Treatment and Recovery Caucus focused on raising awareness and increasing education regarding substance abuse and addiction treatment.

This caucus also aims to help decrease the negative stigma that comes with these diseases and improve the lives of the people around the country suffering from addiction and substance abuse.

Brooks hosted a bipartisan round table discussion at IUPUI with Donnelly, state and federal health officials, doctors, and pharmacists to talk about the best ways to tackle the heroin and opioid abuse epidemic.

CADCA is the national membership organization representing over 5,000 coalitions and affiliates working to make America’s communities safe, healthy and drug-free.

Read More

Norfolk Southern deal concerns Hoosier officials


Members of the Indiana congressional delegation are urging the federal Surface Transportation Board to thoroughly review a possible merger or acquisition of the Norfolk Southern Corp. by Canadian Pacific Railway.

In a news release, U.S. Sen. Joe Donnelly's office said he is leading a bipartisan congressional delegation in pushing the oversight board to ensure that any deal "is in the public interest and will increase competition among rail carriers."

Donnelly and eight members of the Hoosier congressional delegation sent a letter to the federal oversight board in response to Canadian Pacific Railway’s attempts to acquire Norfolk Southern, which employs 2,500 employees in Indiana.

Norfolk Southern also has major operations across Kentucky.

The Candian transportation giant first proposed the merger last fall. The proposal has received a chilly reception in many quarters.

The oversight board has the ability to approve or disapprove mergers and acquisitions in the railroad industry. It is required to assess, among other things, whether a proposed merger would serve the public interest and whether it would benefit competition among rail carriers.

In the letter sent this past week, the members of Congress wrote that "for more than 100 years, Norfolk Southern has been a strong and productive corporate citizen in the State of Indiana, housing a divisional headquarters in Fort Wayne, Indiana, and operating 1,450 route miles of track with numerous rail yards across the state.

"We have heard from many potentially impacted manufacturers and other stakeholders regarding their concerns with the proposed merger.

"We urge you to ensure that any proposed acquisition of Norfolk Southern by Canadian Pacific is in the public interest of Hoosier consumers, manufacturers, and shippers.  Further, we respectfully request that the STB monitor this situation closely to prevent any arrangement that Canadian Pacific would use to circumvent the Surface Transportation Board’s merger review process.”

In addition to employing more than 2,500 Hoosier workers, the letter noted that Norfolk Southern contributes retiree benefits to nearly 1,000 more former employees, spouses, and survivors. It said employment at Norfolk Southern accounted for nearly $182 million in wages in 2014, and the railroad’s expenditures contributed another $70 million in infrastructure investments and $115 million in purchases and payments to vendors throughout our economy.

The letter said the railroad also partners with 17 Indiana short line railroads and two Indiana ports – in Jeffersonville and Burns Harbor – to expand the reach of the "manufacturers, consumers, and communities we represent."

The letter was signed by Sens. Donnelly and Dan Coats and Reps. Susan Brooks, Larry Bucshon, Andre Carson, Luke Messer, Todd Rokita, Peter Visclosky, and Jackie Walorski.

Read More

Brooks Leads Letter Urging the Administration to Act on Zika Virus


WASHINGTON, D.C.— Following Monday’s World Health Organization (WHO) meeting to address the growing threat of Zika virus in the Americas, 70 members of Congress, led by Congresswoman Susan W. Brooks (R-IN), sent a letter to the U.S. Food and Drug Administration (FDA) Acting Commissioner Dr. Stephen Ostroff urging the FDA to add Zika virus to the FDA Tropical Disease Priority Review Voucher (PRV) Program.  

“Zika virus is spreading rapidly in South and Central America.  We must act to ensure that our citizens are protected, and that we are doing everything we can to prevent an outbreak of Zika virus in the United States,” Brooks said. “A natural first step would be for the FDA to exercise its authority and fast-track the development of vaccines or treatments for Zika virus helping save lives and prevent infections.”

The development of new vaccines and treatments often takes several years and costs hundreds of millions of dollars. Adding Zika virus to the FDA Tropical Disease PRV Program will incentivize the research and development of vaccines and therapies for Zika virus by allowing drug manufacturers to request a PRV and receive expedited consideration by the FDA.

 “While the development of vaccines is already underway, it could take years before a vaccine is widely available,” Brooks continued. “In a situation like this—when the WHO has estimated that up to four million people in the Americas will be infected by the end of the year—we don’t have the luxury of time. I will continue to pursue actions and legislative fixes that will help protect our country from dangerous diseases and help arm our researchers with the resources they need to combat the challenges of any potential epidemic or outbreak before it occurs.”

The Zika virus is a mosquito-transmitted infection related to dengue, yellow fever, and West Nile virus, discovered in Uganda in 1947 and not spread widely in the Western Hemisphere until May of last year, when the current outbreak began in Brazil. Symptoms are relatively mild, including fever, rash, joint pain, and red eyes. Only one in five people infected with the virus will develop symptoms, and those who are infected usually do not have to be hospitalized. Zika virus has recently been connected to a surge in infants born with unusually small heads and damaged or underdeveloped brains. There is currently no test widely available for Zika infection, nor is there a vaccine. On Monday, Brooks co-sponsored legislation that would add Zika virus to the FDA Tropical Disease PRV Program, H.R. 4400.

The letter is available online here: PDF icon02052016 Letter to FDA - Zika virus.pdf

Read More

Zika Virus Epidemic Sparks Hoosier Concern


Over 30 Americans have been diagnosed with Zika across 11 states after traveling internationally, including confirmed cases in Illinois. There here have been no confirmed cases of the virus being contracted in the U.S., and Indiana experts say an outbreak here is unlikely.

“We have air conditioning and we don’t have to leave our windows open during the summer,” says Richard Hardy, Professor of Biology at Indiana University. “We have mosquito screens on our windows that can minimize the contact between mosquito and human. While it’s certainly not impossible and I would be surprised if we didn’t start to get isolated cases. I don’t think there’s a likelihood of a takeoff of a real epidemic.”

The Zika virus was discovered in Uganda 1947, but the first confirmed case of the virus in the Americas wasn’t until it was discovered in Brazil this past May.

The virus, primarily transmitted by mosquito bite, is rarely deadly, and only shows symptoms in an estimated 20 percent of those who contract the virus.

The major concern lies in a possible link discovered between pregnant women with Zika and microcephaly, a birth defect that leads to a shrunken head and incomplete brain development. A definitive link has yet to be proven, although cases of microcephaly in Brazil have increased dramatically since the virus was discovered in the country.

“If the link with microcephaly is confirmed, that would obviously cause a lot of concern and panic in terms of what to do from the point of view of pregnant women,” Hardy says. “But again my suspicion is what we’re going to find is that link to microcephaly is one by yes it may be able to cause it but how frequently might be relatively low.”

On Tuesday, U.S. Rep. Susan Brooks, R-Indiana, introduced a bill trying to combat a possible Zika epidemic before it begins. Titled H.R. 4400, the bipartisan bill would put the Zika Virus on the Food and Drug Administration’s Tropical Disease Priority Review Voucher Program.

“There is no vaccine, no treatment for it currently, and so we need to make sure our government processes, the FDA specifically, that we have processes in place to incentivize researchers and companies to focus their attention on creating vaccines and treatments for tropical diseases,” Brooks says.

The Centers for Disease Control has issued travel alerts for the Caribbean, Pacific Islands, Central America and South America. The CDC is advising travelers to protect themselves from mosquito bites.

Read More

Nearly 2,700 Substance Abuse Prevention Specialists Made a ‘Monumental Impact’ at CADCA’s National Leadership Forum


Nearly 2,700 substance abuse prevention and treatment specialists from throughout the country convened at CADCA’s 26th Annual National Leadership Forum this week at the Gaylord National Hotel and Convention Center in National Harbor, Md.

CADCA’s National Leadership Forum is the nation's premier training event for substance abuse prevention and treatment professionals and researchers, featuring more than 70 training courses to help participants learn effective strategies to address drug-related problems in their communities. This four-day training event brings together community drug prevention coalitions from all regions of the country and internationally, government leaders, youth, prevention specialists, addiction treatment professionals, addiction recovery advocates, researchers, educators, law enforcement professionals, and faith-based leaders. Topics ranged from how to address the heroin and opioid epidemic and marijuana use among youth to how to reduce tobacco use and underage drinking.

“The CADCA Forum is more than a training event. It’s a national movement that brings together federal and state officials and community leaders from across the country to find solutions to our nation’s substance abuse problems,” said CADCA Chairman and CEO Gen. Arthur T. Dean. “Attendees leave our Forum with the inspiration, information, and strategies they need to make their communities safe, healthy and drug free.”

The event kicked off Monday with the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Prevention Day including an address from the Surgeon General, Vice Admiral Vivek H. Murthy, M.D., M.B.A. Later that night, attendees visited poster sessions and exhibit booths.

Tuesday, During the National Leadership Plenary, coalitions heard from CADCA’s Chairman and CEO, Gen. Arthur T. Dean, as well as Office of Drug Control Policy Director Michael Botticelli, DEA Acting Administrator Chuck Rosenberg, and Bertha K. Madras, PhD, Professor of Psychobiology, Department of Psychiatry at Harvard Medical School.

Rosenberg discussed the urgency of addressing the heroin use and prescription drug abuse epidemic in this country as well as his agency’s 360 strategy as a way of turning things around.

“If we spent months covering Ebola (in the media), we ought to spend more time highlighting the 129 overdose deaths a day here,” Rosenberg told the packed room.

Dr. Madras addressed the importance of using science to inform the public about marijuana's harm in her keynote presentation.

"This is not a war on drugs. It's a defense of our brains,” said Madras.

The Forum featured two days of Power Sessions, which are unique opportunities to engage with Federal representatives. For example, George F. Koob, PhD, Director of the National Institute on Alcohol Abuse and Alcoholism, provided an overview of the forthcoming NIAAA Strategic Plan and articulate his vision for the future of alcohol research at NIAAA. And Wilson M. Compton, M.D., M.P.E. from the National Institute on Drug Abuse, lead a conversation about the opioid crisis along with discussion of interventions where community coalitions may play a key role.

On Tuesday night, CADCA held a ceremony that honored 179 coalitions that graduated this week from the National Coalition Academy, a year-long training program.

“Our celebration was the most amazing one yet,” said Melissa-Kim Tom, Training Manager, CADCA’s National Coalition Institute.

During Capitol Hill Day on Wednesday, participants heard a legislative update from CADCA’s Public Policy Consultant Sue Thau. CADCA board member The Honorable Mary Bono, Principal, FaegreBD Consulting (Member of Congress 1998-2013) also provided remarks.

Participants at the opening plenary included

·         Congresswoman Susan Brooks (R-Ind.)

·         Congressman Paul Tonko (D-NY)

·         Congressman Bob Dold (R-Ill.)

·         Congresswoman Lucille Roybal-Allard (D-Calif.)

·         Congressman Evan Jenkins (R-WV)

Following the plenary and rally, participants headed up to Capitol Hill for a reception in the Hart Senate Office Building that featured remarks from senators Joe Donnelly (D-Ind.), Rob Portman (R-Ohio), Joe Manchin (D-WV), Chuck Grassley (R-Iowa) and Edward John Markey (D-Mass.) as well as Congressman Elijah Cummings (D-Md.)

Thania Balcorta, a program manager for the Eden Youth and Family Center in Hayward, Calif., organized coalition members in state to visit Sen. Dianne Feinstein’s office on Capitol Hill Day.

“We look forward to continuing our conversation regarding implementation of effective strategies to ensure our local actions are complemented with federal initiatives. We have some lofty goals and we must work together to create a healthier California,” she said.

Nearly 400 youth also attended the meeting to take part in CADCA’s National Youth Leadership Initiative (NYLI), where youth learn how to become substance abuse prevention advocates and powerful community leaders. Many of them were also able to visit their Members of Congress and Senators on Capitol Hill. CADCA also honored coalition leader Ananth Ghosh from Michigan as its Outstanding Youth Leader.

This week, several people also received awards:

National Newsmaker Award

Kimberly Leonard

U.S. News & World Report

Coalition of the Year Award

Hernando County Community Anti-Drug Coalition (Florida)

Coalition in Focus Award

Healthy Communities that Care of Livingston County (New York)

Advocates of the Year awards

Stephanie Armbrister Strutner

Allies for Substance Abuse Prevention, Tennessee

Donna Foisy

Bucks Promise for Youth and Communities Consortium and Council Rock Coalition for Healthy Youth, Pennsylvania

Dose of Prevention Award

Shelby County Drug Free Coalition in Shelbyville, Ind.

Outstanding State Member Award

Idaho’s Office of Drug Policy

Congressional Leadership Awards

Congresswoman Susan Brooks (R-5th/Ind.) Congressman Jeff Fortenberry (R-1st/Neb.) Congressman Paul Tonko (D-20th/NY) Senator Joe Donnelly (D-Ind.) Senator Chris Coons (D-Del.) 

Outstanding National Coalition Academy Instructor awards

Teresa Bishop, Dave Shavel, and Michael Browning 

National Coalition Academy Chairman’s Award

Arlington Youth Health and Safety Coalition in Arlington, Mass.

Today, CADCA bestowed its highest award honor, the National Leadership Award, to Congressman Hal Rogers (R-KY). Chairman Rogers received the award in recognition of the significant contributions he has made to the field of substance abuse prevention and long-standing support of community-based drug prevention.

“From the time that his state of Kentucky was one of the hardest hit by the opioid epidemic, to today, Congressman Rogers has had a Monumental Impact on our field,” said Gen. Arthur T. Dean, CADCA Chairman and CEO. “He truly understands the value of community-based efforts, but also has led the way to bring national leaders together to discuss solutions.”

Rogers accepted the award in person in front of a standing ovation.

“Over the years, we’ve gained invaluable insight regarding the disease of addiction, and what it takes to truly save lives and stop the cycle of abuse. However, there is nothing more powerful than the holistic approach — bringing together professionals and community members from law enforcement, to treatment, and education to raise awareness and effect the change so desperately needed to transform the way we think about and address substance abuse,” Rogers said. “I am honored to accept CADCA’s National Leadership Award and I applaud our community coalitions across the country that continue the grassroots efforts to prevent abuse and to reach out to those who are determined to overcome addiction."

Attendees from all 50 states and several countries and territories including first –timers from Taiwan and the Marshall Islands. First-time attendee Nelson Ramirez attended the Forum to learn more about how to obtain funding for his coalition. A large delegation from the Hawaiian Islands also attended. But, for some coalition members, attending “CADCA” is an annual tradition and is a testament to her that prevention works.

Karra Thomas, a manager with the Detroit Wayne Mental Health Authority in Detroit, is part of a network in her city that includes 13 coalitions, said, “Each year, I look forward to this phenomenal CADCA National Leadership Forum. This conference is one of the highlights of true Prevention! From the POWER of the MOVEMENT...We have been on a MISSION and have a total of 10 attending such as coalitions, programs and Board Members from Detroit Wayne Mental Health Authority here to make an IMPACT! 

Download the “I attended” news release template and let your community media know you are proud to be attending CADCA’s Forum.

For more information about CADCA’s National Leadership Forum, visit

Read More

Loading legislation ... one moment please
Loading votes ... one moment please

Contact Information

1505 Longworth HOB
Washington, DC 20515
Phone 202-225-2276
Fax 202-225-0016

Congresswoman Susan Brooks represents the 5th District of Indiana, which spans eight diverse counties throughout the central part of the Hoosier State. As a new member of Congress, she currently serves on the Education and Workforce, Homeland Security and Ethics Committees. She is also the Chairwoman of the Subcommittee on Emergency Preparedness, Response and Communications.

Her strong background in both the public and private sectors includes experience as a proven difference maker in areas such as public safety, homeland security, counter-terrorism and economic development.

Before joining the House of Representatives, Susan served as Senior Vice President and General Counsel for Ivy Tech Community College. Collaborating with a wide network or stakeholders, she implemented workforce development strategies aiming to enhance job training and placement for thousands of Hoosier residents.

In 2001, President George W. Bush appointed Susan as U.S. Attorney for the Southern District of Indiana. Serving as the chief federal law enforcement officer for a majority of the Hoosier state, she received bi-partisan acclaim for efforts to battle mortgage fraud, gun violence, drug trafficking, gangs, child exploitation and identity theft.

Susan also earned recognition as Deputy Mayor of Indianapolis during the Steve Goldsmith administration, where she provided oversight on public safety operations and drove community dialogue on vital civic issues. Over her tenure, she managed police, fire and emergency response efforts while serving on boards related to criminal justice, community corrections, violence reduction and race relations.

Susan practiced law at the Indianapolis firm of Ice Miller and also served as a criminal defense attorney for Indianapolis based McClure, McClure and Kammen.

After receiving her undergraduate degree from Miami University of Ohio, Susan pursued a Juris Doctor (J.D.) from the Indiana University Robert H. McKinney School of Law. In May of 2013, Susan was awarded an honorary Doctor of Public Service degree from Marian University in Indianapolis. She resides in Carmel, Indiana with her husband David and they have two young adult children.

Serving With

Jackie Walorski


Marlin Stutzman


Todd Rokita


Luke Messer


Larry Bucshon


Todd Young


Recent Videos